Akers Biosciences Inc Current Ratio 2012-2018 | AKER

Akers Biosciences Inc current ratio from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Akers Biosciences Inc Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $0.01B $0.00B 3.38
2018-09-30 $0.01B $0.00B 3.44
2018-06-30 $0.01B $0.00B 5.71
2018-03-31 $0.01B $0.00B 8.09
2017-12-31 $0.01B $0.00B 4.36
2017-09-30 $0.00B $0.00B 2.35
2017-06-30 $0.01B $0.00B 3.15
2017-03-31 $0.01B $0.00B 3.92
2016-12-31 $0.00B $0.00B 1.88
2016-09-30 $0.00B $0.00B 2.94
2016-06-30 $0.00B $0.00B 2.51
2016-03-31 $0.01B $0.00B 3.13
2015-12-31 $0.01B $0.00B 3.88
2015-09-30 $0.01B $0.00B 6.57
2015-06-30 $0.01B $0.00B 8.48
2015-03-31 $0.01B $0.00B 10.26
2014-12-31 $0.01B $0.00B 7.08
2014-09-30 $0.01B $0.00B 14.32
2014-06-30 $0.02B $0.00B 15.69
2014-03-31 $0.02B $0.00B 16.08
2013-12-31 $0.00B $0.00B 2.05
2013-09-30 $0.00B $0.00B 0.00
2013-06-30 $0.00B $0.00B 0.00
2013-03-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B $0.00B 1.17
2011-12-31 $0.00B $0.00B 3.66
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.011B $0.002B
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $133.667B 26.06
Medtronic (MDT) Ireland $114.132B 16.69
Stryker (SYK) United States $69.756B 24.90
Boston Scientific (BSX) United States $49.905B 24.25
Baxter (BAX) United States $39.019B 25.03
Zimmer Biomet Holdings (ZBH) United States $25.114B 16.07
Smith & Nephew SNATS (SNN) United Kingdom $16.786B 0.00
Canopy Growth (CGC) Canada $16.315B 0.00
ResMed (RMD) United States $14.544B 27.58
Aurora Cannabis (ACB) Canada $9.179B 64.71
Bio-Rad Laboratories (BIO) United States $8.795B 50.45
Perrigo (PRGO) Ireland $6.734B 10.92
Hill-Rom Holdings (HRC) United States $6.397B 19.79
GW Pharmaceuticals (GWPH) United Kingdom $4.994B 0.00
Insulet (PODD) United States $4.964B 1664.20
ICU Medical (ICUI) United States $4.636B 28.71
Haemonetics (HAE) United States $4.354B 38.62
Hutchison China MediTech (HCM) China $3.962B 0.00
Agios Pharmaceuticals (AGIO) United States $3.443B 0.00
Neogen (NEOG) United States $3.004B 48.85
NuVasive (NUVA) United States $2.967B 25.77
Quidel (QDEL) United States $2.487B 22.25
National Vision Holdings (EYE) United States $2.276B 44.77
Aphria (APHA) $1.957B 0.00
HEXO (HEXO) $1.474B 0.00
Phibro Animal Health (PAHC) United States $1.338B 19.24
VAREX IMAGING (VREX) United States $1.234B 24.16
Cardiovascular Systems (CSII) United States $1.212B 870.25
AtriCure (ATRC) United States $1.076B 0.00
Lantheus Holdings (LNTH) United States $0.957B 25.86
Omeros (OMER) United States $0.929B 0.00
PetIQ (PETQ) United States $0.865B 24.76
Cerus (CERS) United States $0.831B 0.00
MacroGenics (MGNX) United States $0.820B 0.00
NanoString Technologies (NSTG) United States $0.781B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.725B 24.66
TG Therapeutics (TGTX) United States $0.717B 0.00
Evolus (EOLS) United States $0.708B 0.00
OraSure Technologies (OSUR) United States $0.589B 25.68
Surmodics (SRDX) United States $0.584B 84.94
LeMaitre Vascular (LMAT) United States $0.555B 26.37
Meridian Bioscience (VIVO) United States $0.538B 16.02
Quanterix (QTRX) United States $0.515B 0.00
Insys Therapeutics (INSY) United States $0.332B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.19
BioLife Solutions (BLFS) United States $0.302B 124.61
Vapotherm (VAPO) United States $0.287B 0.00
Rockwell Medical (RMTI) United States $0.270B 0.00
Cytosorbents (CTSO) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.172B 18.38
Bovie Medical (APYX) United States $0.140B 0.00
Chimerix (CMRX) United States $0.138B 0.00
Fonar (FONR) United States $0.128B 6.85
Chembio Diagnostics (CEMI) United States $0.122B 0.00
Surface Oncology (SURF) United States $0.114B 0.00
United-Guardian (UG) United States $0.089B 20.32
Female Health (VERU) United States $0.088B 0.00
InfuSystems Holdings (INFU) United States $0.085B 0.00
Neurotrope (NTRP) United States $0.075B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 19.86
GUARDION HEALTH (GHSI) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.024B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00